Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
MGM Resorts’ casino workers in Detroit reject new labor deal
Post Content Post Views: 94
Shares of American Eagle plummet 17% on unimpressive holiday forecast
American Eagle issued a holiday forecast that failed to impress Wall Street, following a string of retailers who’ve issued muted guidance for the season. Post Views: 101
Binance’s Zhao pleads guilty, steps down to settle US illicit finance probe
Post Content Post Views: 77
Ideanomics regains compliance with Nasdaq listing rules
Post Content Post Views: 74
South African ‘Blade Runner’ Pistorius gets parole a decade after killing girlfriend
Post Content Post Views: 70
Blinken to attend NATO ministerial meeting on Russia, Balkans – US State Dept
Post Content Post Views: 79